Neurospine Hospital & Revive Critical Care
About Doctor
DR. JAYANT KELWADE
MBBS, MD, DNB
ENDOCRINOLOGY
Dr. Jayant Kelwade Agrawal has 12 Years of Experience in Endocrinology. Senior Resident (Endocrinology), CARE Hospital, Hyderabad. 21 February 2014 to 31 October 2017 (3 years, 8 months).Consultant, Intensive care unit, Avanti Hospital, Nagpur October 2013- February 2014.Assistant Medical Officer (Medicine department), Siddharth Municipal General Hospital, Goregaon, Mumbai, Maharashtra. September 2012- September 2013
Research / Publications
- Jayant Kelwade, Sethi BK Vaseem A, Nagesh VS Sodium glucose co-transporter 2 inhibitors and Ramadan: Another string to the bow. Indian J Endocr Metab 2014,18 874-5
- Jayant Kelwade, Sethi BK, Nagesh SV, Vaseem A. A case of “pseudo-ketoacidosis Indian J Endocr Metab 2014,18 743
- Bipin Kumar Sethi, V Sri Nagesh, Jayant Kelwade, Ayesha Vaseem. Unique Interaction of Saroglitazar with Insulin J Assoc Physicians India 2015 Dec;63(12) 95.
- Ayesha Vaseem, Bipin K Sethi, Jayant V Kelwade, Mazher Ali SGLT2 Inhibitor and DPP4 Inhibitor Co-Administration In Type 2, Diabetes-Are We Near The “Promised Land� RRJPTS, Volume 4, Issue 1, March, 2016
- Jayant Vishwanath Kelwade, K D Modi, Nirmal Kumar, Harsh Parekh Hypercalcemia and electrocardiogram changes. Indian J Endocrinol Metab 2016 Nov-Dec;20(6):892-893
- Bipin Kumar Sethi, V Sri Nagesh, Jayant Kelwade, Harsh Parekh, Vaibhav Dukle Utility of Cinacalcet in Familial Hypocalciuric Hypercalcemia. Indian J Endocrinol Metab 2017, 21(2) 362-363)
- Jayant Kelwade, Harsh Parekh, Vaibhav Dukle, Bipin Kumar Sethi How many oral antidiabetic drugs before insulin? Indian J Endocrinol Metab 2017 Jan-Feb;21(1) 249-250